GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Accelerator Applications SA (NAS:AAAP) » Definitions » Cash Receipts from Loans

Advanced Accelerator Applications (Advanced Accelerator Applications) Cash Receipts from Loans


View and export this data going back to 2015. Start your Free Trial

What is Advanced Accelerator Applications Cash Receipts from Loans?

Cash Receipts from Loans only applicable to companies reporting Cash Flow from Operations in direct method.


Advanced Accelerator Applications (Advanced Accelerator Applications) Business Description

Traded in Other Exchanges
N/A
Address
Advanced Accelerator Applications SA is a French-based radiopharmaceutical company. It develops, produces, and commercializes molecular nuclear medicine diagnostic and therapeutic products. The molecular nuclear medicine is a medical specialty that uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases including cancer. The company includes a portfolio of six diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. Its PET and SPECT are imaging techniques in molecular nuclear diagnostics with applications in clinical oncology, cardiology and neurology. Its other diagnostic product is Gluscan, its branded fluorodeoxyglucose PET imaging agent.